Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2

Abstract

Reactive infectious mucocutaneous eruption (RIME) is a recently proposed term used to describe cases of postinfectious rash and mucositis. This entity was previously termed mycoplasma-induced rash and mucositis (MIRM); however, numerous cases have been described with non Mycoplasma pneumoniae-associated causes. These patients are typically adolescents and have a prodromal cough followed by severe mucositis of 2 or more mucous membranes, with or without a cutaneous rash. Here, we report a case of RIME secondary to SARS-CoV-2 that was refractory to corticosteroids and improved with cyclosporine.